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$EVWUDFW 24 
Background 25 
Serious mental illness (SMI), which encompasses a set of chronic conditions such as 26 
schizophrenia, bipolar disorder and other psychoses, accounts for 3.4m (7%) total bed 27 
days in the English NHS. The introduction of prospective payment to reimburse 28 
hospitals makes an understanding of the key drivers of length of stay (LOS) 29 
imperative. Existing evidence, based on mainly small scale and cross-sectional 30 
studies, is mixed. Our study is the first to use large-scale national routine data to track 31 
(QJOLVKKRVSLWDOV¶/26IRU patients with a main diagnosis of SMI over time to 32 
examine the patient and local area factors influencing LOS and quantify the provider 33 
level effects to draw out the implications for payment systems. 34 
Methods 35 
We analysed variation in LOS for all SMI admissions to English hospitals from 2006 36 
to 2010 using Hospital Episodes Statistics (HES). We considered patients with a LOS 37 
of up to 180 days and estimated Poisson regression models with hospital fixed effects, 38 
separately for admissions with one of three main diagnoses: schizophrenia; psychotic 39 
and schizoaffective disorder; and bipolar affective disorder. We analysed the 40 
independent contribution of potential determinants of LOS including clinical and 41 
socioeconomic characteristics of the patient, access to and quality of primary care, 42 
and local area characteristics. We examined the degree of unexplained variation in 43 
provider LOS. 44 
Results 45 
Most risk factors did not have a differential effect on LOS for different diagnostic 46 
sub-groups, however we did find some heterogeneity in the effects. Shorter LOS in 47 
the pooled model was associated with co-morbid substance or alcohol misuse (4 48 
days), and personality disorder (8 days). Longer LOS was associated with older age 49 
(up to 19 days), black ethnicity (4 days), and formal detention (16 days). Gender was 50 
not a significant predictor. Patients who self-discharged had shorter LOS (20 days). 51 
No association was found between higher primary care quality and LOS. We found 52 
large differences between providers in unexplained variation in LOS. 53 
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Conclusions 54 
By identifying key determinants of LOS our results contribute to a better 55 
understanding of the implications of case-mix to ensure prospective payment systems 56 
reflect accurately the resource use within sub-groups of patients with SMI.  57 
 58 
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%DFNJURXQG 64 
Serious mental illness (SMI) encompasses a range of chronic and frequently disabling 65 
conditions including schizophrenia, bipolar disorder and psychoses. These conditions 66 
are associated with substantial morbidity and mortality. The life expectancy of SMI 67 
patients is 10 to 15 years shorter than the general population in England [1], and  15 to 68 
20 years shorter in Denmark, Finland and Sweden [2]. A recent global morbidity 69 
study attributed 3.5% of total Years Lost to Disability to schizophrenia and bipolar 70 
disorder combined [3]. The two diseases alone are estimated to constitute 1.5% of the 71 
total Disability Adjusted Life Year burden of disease for the UK in 2010 [4] and 1.1% 72 
in 21 regions worldwide [5]. People with SMI are at higher risk of hospitalisations 73 
than the general population [6, 7] as physical comorbidity is more common [8, 9]. 74 
SMI is associated with increased treatment costs [10] and hospitalisation for this 75 
patient group represents a significant proportion of health care resource use. In 76 
England, these illnesses account for 3.4 million or 7.2% of total bed days [11]. This 77 
paper examines the key patient and local area determinants of inpatient length of stay 78 
(LOS) for patients with a main diagnosis of SMI and examines the variation in LOS 79 
between hospital providers in England. 80 
 81 
The delivery of mental health services and the incentives that service providers face 82 
have changed radically in the last few decades. Most western health care systems have 83 
deinstitutionalised care for patients with mental health problems and shifted treatment 84 
from secondary care settings into the community [12]. This has led to significant 85 
reductions in average LOS and also in overall numbers of psychiatric beds. More 86 
recently, policy shifts have focused on changes in funding arrangements for mental 87 
health care as a response to pressure to contain costs. Whereas most health care 88 
systems reimburse the full costs for providers of inpatient care, several are 89 
considering the use of activity-based prospective payment systems, similar to those 90 
already in use in the acute physical care setting, in order to reduce costs [13]. Canada 91 
(Ontario), Australia and New Zealand have developed case-mix classification systems 92 
for mental health services which have included information on diagnosis. In Australia 93 
and New Zealand provider factors were shown to significantly drive cost variations 94 
making the classification systems unsuitable for provider payment [13]. 95 
 96 
 - 5 - 
In England, the National Health Service (NHS) is moving away from traditional block 97 
contracts towards a more transparent prospective funding for providers called the 98 
National Tariff Payment System (NTPS) (formerly known as Payment by Results 99 
(PbR) [14]). Under the NTPS, patients are classified into one of 21 care clusters based 100 
on need and severity, rather than diagnostic coding. These clusters are in turn grouped 101 
into three super-classes corresponding to non-psychotic, psychosis and organic mental 102 
illness. The intention is that each cluster will have a fixed national price based on the 103 
national weighted average cost of admitted and non-admitted care. Each cluster has a 104 
specific review period attached to it with payments made to cover all care during the 105 
cluster review period. Whilst the current implementation of NTPS focuses on the 106 
development of locally negotiated cluster prices, the move towards a national fixed 107 
price payment system would provide a strong incentive to control costs and should 108 
therefore encourage providers to reduce LOS. Evidence from the US has reported 109 
reductions in LOS following the introduction of a prospective payment system in 110 
psychiatric care, as well as reductions in LOS due to anticipatory effects  prior to 111 
payments starting [15, 16]. LOS for inpatient care is a major driver of resource use 112 
and is highly correlated with hospital costs, especially when care is labour-intensive 113 
as is the case in mental health [17]. Reductions in LOS may reduce the very high 114 
psychiatric bed occupancy rates observed in the English NHS and the associated 115 
difficulties in accessing acute psychiatric beds for severely ill patients in crisis [18], 116 
although driving down reductions in LOS too far can impact on quality and outcomes 117 
and may increase readmission rates [19-21]. 118 
 119 
Differences in LOS across providers can reflect differences in patient needs, but can 120 
also be indicative of differences in treatment philosophies and practice patterns [22] 121 
and in efficiency of care provision. A better understanding of the factors which 122 
determine LOS is imperative for the design of payment systems, e.g. by identifying 123 
high cost casemix profiles. Estimates of how LOS varies between providers after 124 
allowing for differences in case-mix can also provide measures of the extent to which 125 
LOS may be amenable to potential reductions by high cost providers in response to 126 
the introduction of a prospective payment system. Given the high proportion of bed 127 
days and the high cost associated with the care of people with psychotic disorders, as 128 
well as the fact that psychosis is one of the three super-classes in the NTPS, this study 129 
focuses on the determinants of LOS for people with SMI. 130 
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 131 
There is conflicting evidence about the key determinants of hospital LOS for people 132 
with SMI. This may in part reflect the methodological weaknesses in many previous 133 
studies. Many studies are cross-sectional with small samples split into case-control 134 
groups by mean or median LOS in order to examine the difference between long and 135 
short-stays, typically using logistic regression. Comparing sub-populations in this way 136 
leads to inconsistent findings as LOS is typically skewed and sub-populations may be 137 
small [12].  Single site studies are not generalisable to other settings with a different 138 
patient case-mix [23]. Finally, SMI covers a range of clinical sub-groups with 139 
different treatment requirements. Studies to date have typically pooled clinical sub-140 
groups to increase their sample size, making the untested assumption that risk factors 141 
will have the same effect on all sub-groups.  142 
 143 
This study has two aims. First, we aim to assess the independent effects of patient 144 
characteristics (case-mix) and local area characteristics on LOS and study whether 145 
there is heterogeneity in those effects across patient sub-groups with SMI. We 146 
improve on previous work by using large scale administrative datasets to investigate 147 
factors associated with LOS. Second, we aim to assess the degree of unexplained 148 
variation in provider LOS i.e. the variation which remains after controlling for the 149 
patient and local area characteristics in our model. The residual unexplained variation 150 
in LOS may be interpreted as the element most amenable to influence by 151 
policymakers and providers. Thus it may help to define the limits on the extent to 152 
which a prospective payment system for providers may be successful in reducing LOS 153 
and costs. 154 
'HWHUPLQDQWVRIOHQJWKRIVWD\IRUSDWLHQWVZLWK155 
VHULRXVPHQWDOLOOQHVV 156 
We searched the literature for key determinants of LOS for patients with SMI to 157 
identify a relevant set of explanatory variables for subsequent analysis. We searched 158 
several bibliographic databases (e.g. PubMed, EMBASE, PsycINFO) to identify 159 
relevant literature published between 1946 and 2014. Our search strategy (see 160 
Appendix 1) included terms for schizophrenia, psychotic disorders, bipolar disorder; 161 
for trials, cohort studies or systematic reviews; and length of stay. Titles were 162 
screened and abstracts were checked for relevance from 132 articles. We found 15 163 
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studies with LOS as the primary or secondary outcome for patients with SMI 164 
specifically. We also identified 5 studies from alternative sources such as suggestions 165 
from experts. 166 
 167 
Most studies consider 3 groups of predictor variables: (a) socio-demographic 168 
characteristics of patients (e.g. age, gender, living arrangements, degree of social 169 
support, ethnicity, insurance status); (b) clinical characteristics (e.g. psychiatric 170 
diagnosis, severity, legal status/compulsory admission, psychiatric or physical co-171 
morbidities, measure of functioning, previous admissions, medication); and (c) 172 
characteristics of hospitals or the health care system (e.g. type of hospital, measures of 173 
quality of care). 174 
 175 
While some studies covered a wide array of determinants, many of these were found 176 
not to be significant and the results for some factors differed across studies. Socio-177 
demographic characteristics which were associated with increased LOS for patients 178 
with SMI include being single / not married [24-26], having accommodation or 179 
housing problems [12, 26-28], having no educational qualification [12, 29], being on a 180 
national health insurance plan [30, 31], and being in receipt of welfare [29], whilst 181 
higher deprivation was associated with shorter LOS in another study [32]. There is 182 
limited evidence of an effect for ethnicity [25]. Being a foreigner was associated with 183 
increased LOS in one study [29] while being a migrant was associated with reduced 184 
LOS in another [12]. Having family ties or social support was also associated with 185 
reduced LOS [33, 34]. Older age was associated with increased LOS in some studies 186 
[25, 30, 32, 33, 35], and reduced LOS in others [29, 31, 36]), while male gender was 187 
associated with increased LOS in some studies [24, 30, 31], and reduced LOS in 188 
others [25, 26, 32, 37]).   189 
 190 
Clinical characteristics which were associated with increased LOS for patients with 191 
SMI include: a primary diagnosis of schizophrenia or psychosis [25-27, 29, 31, 32, 192 
35, 36, 38, 39] or a mood disorder [35] although some studies found diagnosis to be a 193 
poor predictor of LOS [39, 40]. Other characteristics associated with increased LOS 194 
were higher severity as measured by e.g. the Brief Psychiatric Rating Scale (BPRS) 195 
[24, 41, 42] or the Global Assessment of Functioning (GAF) [37] or other severity 196 
indicators [28, 39]. Co-morbidities were associated with increased LOS in some 197 
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studies [24, 29], while having no secondary diagnoses increased LOS in other studies 198 
[30]. A diagnosis of co-morbid substance abuse was associated with a reduced LOS 199 
[35, 37, 39] as was personality disorder [37]. Prior hospitalisation was associated with 200 
increased LOS in some studies [32, 35, 38] but with lower LOS in other studies [29]. 201 
Previous violence / forensic history was positively associated with LOS [28, 33] as 202 
was use of seclusion or restraint [12, 37]. Legal status/compulsory admission as a risk 203 
factor was positively associated with LOS in some studies [23, 38], but negatively in 204 
others [25, 26]. Being on an open rather than a locked ward was associated with 205 
reduced LOS [29] as was having an emergency admission or weekend admission [32] 206 
and being discharged against medical advice [26]. Receiving psychopharmacological 207 
medication, such as neuroleptics, antidepressants and lithium was associated with 208 
reduced LOS in one study [29] and increased LOS in another [27]. Being admitted 209 
from another institution was positively associated with LOS in one study [34] and 210 
negatively in another [12]. 211 
 212 
Finally, characteristics of hospitals and the healthcare system which were positively 213 
associated with LOS include the patient being treated at a psychiatric hospital, rather 214 
than another type of hospital [30, 31], a higher number of beds [25, 30, 31], a higher 215 
proportion of male patients [31], and a higher proportion of elderly patients [31]. The 216 
number of health care professionals employed was associated with reduced LOS [30, 217 
31] as was a shorter distance from patient¶VSODFHRI residence to hospital [24]. There 218 
was also evidence of marked regional variation in LOS [12, 38]. 219 
0HWKRGV 220 
Study population 221 
Our study population was all patients aged 18 or over and admitted with a primary 222 
diagnosis of SMI to a mental health hospital in England during the study period April 223 
2006 to October 2010. All patients were followed until March 2011. SMI patients 224 
were identified using ICD-10 diagnostic codes in the primary diagnosis field of their 225 
admission record. Many studies focus on a wide range of mental health conditions and 226 
thus tend to group the primary diagnoses according to type of disorder by ICD-10 227 
code (e.g. F2, F3) which also reflects severity to some degree [12, 43]. We focussed 228 
on individual conditions within SMI to more accurately assess the impact on resource 229 
use for each condition. In addition to considering the effects of patient and local area 230 
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characteristics on LOS for all SMI patients in a pooled model (1), we also examined 231 
patients with three types of SMI: (2) schizophrenia (F20); (3) schizoaffective 232 
disorders, and schizotypal and delusional disorders (F21- F29); and (4) bipolar and 233 
mood affective disorders (F30-F31) (see Table 1).  234 
Table 1 about here 235 
Data sources 236 
Our study combined several datasets. Record-level data on hospital admissions were 237 
obtained from the Hospital Episodes Statistics (HES) which covers all NHS-funded 238 
secondary care in England. These data are reported as Finished Consultant Episodes 239 
(FCEs) and we converted these to continuous inpatient spells (CIPS) (admissions). 240 
Using CIPS has the advantage that it reduces coding errors e.g. where patients leave 241 
hospital for a weekend but are not discharged, they may otherwise be coded as a new 242 
admission on their return. We used HES to derive our dependent variable (LOS) and a 243 
range of demographic and clinical characteristics. Individual patient records were 244 
linked over time through a unique patient identifier, based on the pDWLHQW¶V1+6245 
number. Data on local area-level characteristics (i.e. the number of people resident in 246 
an NHS community psychiatric establishment, and urban status) were sourced from 247 
the Office of National Statistics (ONS). These data were derived from the 2001 248 
Census and were available at small area level (Lower Super Output Area (LSOA)). 249 
Data on the number of incapacity benefit claimants at small area level were obtained 250 
from the Department of Work and Pensions. Data on access to and quality of care for 251 
patients with SMI received in primary care were extracted from the Quality and 252 
Outcomes Framework (QOF) dataset and the GP Patient Survey (GPPS) dataset and 253 
linked to HES through the practice identifier and the year. Appendix 2 provides a full 254 
list of datasets and sources. As confirmed by the University of York Research Ethics 255 
Committee, no ethical approval was required for this study since it is classed as low 256 
risk due to minimal burden or intrusion for participants as it is based on the analysis 257 
of anonymised secondary data. 258 
Data 259 
LOS for each admission was calculated as the difference between the dates of 260 
admission to and discharge from hospital. All patients were admitted and discharged 261 
from the same hospital. Patients with unfinished episodes were dropped from the 262 
sample.  263 
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 264 
For each admission, we also extracted information from HES on socio-demographic 265 
variables such as age (ZHFDWHJRULVHGSDWLHQWV¶DJHLQWRVHYHQ-year bands and used 266 
the first band (18-24) as a reference category), gender, ethnicity, and carer support; 267 
clinical variables including main and secondary diagnoses, previous history of 268 
psychiatric care, legal status - whether the patient was detained under the Mental 269 
Health Act; and the mode of discharge (discharged by clinician, self-discharged, or 270 
died in hospital).  271 
 272 
In relation to co-morbidity, previous studies adopt a range of different approaches, 273 
with many studies including co-morbidity in terms of secondary diagnoses of a mental 274 
health condition, rather than other clinical conditions. Some ignore this aspect 275 
completely [31]; others record whether a secondary diagnosis was present or absent 276 
[29]; and many tend to focus only on a secondary diagnosis related to substance or 277 
alcohol misuse or personality disorder [23, 35, 37].   278 
 279 
We counted the total number of co-morbidities for a patient up to a maximum of 13, 280 
including secondary diagnoses for mental health and non-mental health conditions. 281 
We imposed a limit of 13 to account for the change in the number of available fields 282 
in HES for recording secondary diagnoses (ranging from 13 in 2006 to 19 in year 283 
2010). We also derived a set of indicator variables for a secondary diagnosis of co-284 
morbid alcohol and substance misuse (F10-F19) [35, 37] and co-morbid personality 285 
disorder (F60) [37]. 286 
 287 
We derived a number of neighbourhood level characteristics to account for the local 288 
context, e.g. the deprivation profile. We extracted data on the proportion of the local 289 
population who resided in NHS community psychiatric establishments. Ideally, we 290 
would have used a measure based on the number of beds available each year (rather 291 
than occupancy at one time point). However, as long as demand for community beds 292 
is at least equal to supply, the measure was considered a reasonable approximation of 293 
capacity and therefore a likely proxy for local area need. Socio-economic status was 294 
approximated by the percentage of the local population claiming incapacity benefit for 295 
a mental disorder. Since the LSOA population (i.e. denominator) changed over time, 296 
we estimated moving averages for both these variables. We then categorised the 297 
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deprivation measure (i.e. incapacity claimants) into quintiles. Finally, we accounted 298 
for whether the local area ZDVµXUEDQ¶GHILQHGDVKDYLQJDSRSXODWLRQDERYH, 299 
XVLQJDGXPP\YDULDEOHEDVHGRQWKHµ5XUDODQG8UEDQ$UHD&ODVVLILFDWLRQIRU6XSHU300 
2XWSXW$UHDV¶IURP216This variable was assumed to be time-invariant.  301 
 302 
Effective primary care may shorWHQSDWLHQWV¶LOS in two ways: firstly, if hospitals can 303 
be confident that the patient will be followed up by the GP practice they may decide 304 
to discharge the patient more quickly. Secondly, patients with better access to primary 305 
care prior to admission may require a shorter stay once admitted.  306 
 307 
The Quality and Outcomes Framework (QOF) is a pay-for-performance scheme in 308 
primary care which includes a set of indicators for SMI against which practices score 309 
points according to their level of achievement. We extracted data on the proportion of 310 
SMI patients with a comprehensive care plan documented, which we interpreted as a 311 
measure of quality and continuity of care. To approximate accessibility of primary 312 
care services, we extracted the proportion of patients reported to have been seen by 313 
their GP within 48 hours, derived from the annual GP survey. Both variables were 314 
measured at GP practice level and linked to the HES record through unique practice 315 
and year identifiers. 316 
Exclusions  317 
We excluded admissions with very long LOS, defined as stays over 180 days 318 
(approximately 6 months), to reduce the effect of unusually long stay patients on the 319 
stability of the estimates and focus on a more homogeneous patient population that 320 
reflects the majority of cases seen in the inpatient setting. These long-stay patients 321 
tend to be different with respect to observable characteristics. For example, those 322 
patients staying longer than 180 days are twice as likely to be detained and 1.5 times 323 
as likely to have a main diagnosis of schizophrenia (ICD-10: F20). To ensure our 324 
analysis included all patients who could have stayed in hospital up to the upper 325 
threshold, we excluded admissions that occurred after the 2nd October 2010 326 
calculated as 31st March 2011 minus 180 days. 327 
 328 
We also excluded admissions to mental health providers which treated fewer than 10 329 
admissions for the particular clinical diagnosis sub-category over our study period 330 
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(see study population). Finally, patients were excluded if they were recorded as living 331 
outside of England.  332 
Analysis 333 
Poisson regression models were estimated to relate observed LOS to patient 334 
characteristics, neighbourhood characteristics and indicators of primary care. All 335 
models included hospital fixed effects to account for unobserved differences in 336 
hospital policies, efficiency, and case-mix. Hence, coefficients are estimated from 337 
within-hospital variation only. We included time fixed effects to account for common 338 
temporal trends. No exposure term was defined. Poisson regression was appropriate 339 
for these data due to the skewed distribution of LOS. It was also preferable to 340 
logarithmic transformations, which are commonly used to analyse LOS, because it 341 
estimated the conditional mean on the scale of interest and did not suffer from re-342 
transformation bias [44, 45]. Poisson regression is increasingly used to analyse length 343 
of stay and cost data, and has been found to fit those data at least as well as for 344 
example, Weibull or Cox proportional hazard survival models [46, 47]. Since 345 
censoring was not a major concern in this study - only 2.7% of patients self-346 
discharged or died in hospital - we decided to model these factors as covariates. The 347 
Poisson estimator produces unbiased point estimates as long as the conditional mean 348 
is correctly specified. We obtained robust Huber-White standard errors to account for 349 
over-dispersion or other misspecification of the variance function [48].  350 
 351 
Estimated effects are reported as average partial effects (APEs), which represent the 352 
expected change in LOS for a unit change in the independent variable. APEs were 353 
calculated conditional on hospital fixed effects, which we recovered after estimation 354 
using the procedure outlined in [48] (p.281). We also calculated Incidence Rate Ratios 355 
(IRRs) with two-sided 95% confidence intervals, where values greater than 1 indicate 356 
an increase in relative risk of incurring an additional inpatient day.  357 
 358 
All models were estimated on the pooled sample of all SMI admissions and separately 359 
for the three groups of SMI admissions. We compared the estimated effects across 360 
groups to explore heterogeneity in the effect of risk factors. We also correlated the 361 
hospital fixed effects estimates across groups to examine whether unobserved hospital 362 
characteristics had a similar effect on LOS for the different patient groups.  363 
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 364 
All analyses were conducted in Stata 13. 365 
5HVXOWV 366 
Descriptive analysis 367 
Our sample included 89,510 admissions for patients treated in 67 hospitals and who 368 
were registered with 7,792 GP practices. Across all five years, the median annual 369 
volume of admissions with a primary diagnosis of SMI was 270. 370 
 371 
Approximately 42.7% of admissions had a recorded primary diagnosis of 372 
schizophrenia, and another 33.4% were diagnosed with bipolar disorder or a manic 373 
episode (Table 1). However, there was substantial variation in intake across providers. 374 
Figure 1 shows the proportion of patients in each of the three sub-groups by provider. 375 
For some providers, 55% of the SMI patients were diagnosed with schizophrenia, 376 
whereas the proportion in other providers was less than 30%. Similarly, the proportion 377 
of patients with bipolar or mood affective disorder was around 40% (and one as high 378 
as nearly 60%) in some providers, but was just over 20% in other hospitals.  379 
 380 
Figure 1 about here 381 
 382 
Figure 2 shows a histogram of the distribution of LOS. LOS fell very slightly over 383 
time by on average around 0.2 to 0.4 days per year across the three sub-groups (Table 384 
2) and LOS was longest for individuals with a main diagnosis of schizophrenia (F20) 385 
or schizoaffective disorder (F25) (Figure 3). 386 
 387 
Figure 2 about here 388 
Table 2 about here 389 
Figure 3 about here 390 
Estimation results - overview 391 
Table 3 shows the average partial effects (APEs) estimates for the pooled model 392 
(column (1)) and then separately for the three types of SMI patient (columns (2) to 393 
(4)). Table 4 presents the results as Incidence Rate Ratios (IRR). In the pooled model, 394 
the majority of diagnostic groups had a shorter LOS than schizophrenia, some as 395 
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much as 20 days shorter (F22). Diagnosis was a key predictor of LOS in the pooled 396 
model. Results were broadly consistent across the three diagnostic groups of patients. 397 
However, there were some differences in LOS across diagnoses: F23, F28 and F29 398 
had significantly shorter LOS than schizotypal disorder (F21) of between 9 and 17 399 
days. People with bipolar affective disorder had a significantly longer LOS of 7 days 400 
compared to those suffering from a manic episode (F30).  401 
 402 
Table 3 about here 403 
Table 4 about here 404 
Estimation results ± individual characteristics 405 
Our findings suggest that most independent risk factors do not have a differential 406 
effect for different diagnostic sub-groups. However we do note some heterogeneity in 407 
the effects. In terms of patient demographics and clinical characteristics, we found an 408 
age gradient with patients from age 65 and above with schizophrenia, and from age 55 409 
and above for the other diagnostic subgroups and in the pooled model, exhibiting 410 
progressively longer LOS compared to 18-24 year-olds. This age gradient for the 65 411 
to 74-year old age group, relative to the 18 to 24-year old age group, was 11 days in 412 
the pooled model and ranged from 6 days for the schizophrenia subgroup, 14 days for 413 
schizoaffective disorder and 19 days for bipolar disorder. Gender was not a significant 414 
predictor of LOS.  Longer LOS was associated with formal detention (16 days in the 415 
pooled model and between 15 days for schizoaffective disorder and 19 days for 416 
schizophrenia) and with black ethnicity (around 4 days), although detained patients 417 
with black ethnicity had shorter LOS than detained white patients (see interactions in 418 
Table 4). Having an informal carer was associated with longer LOS in the pooled 419 
model (3 days) although this was not significant in all models (2) to (4). Patients with 420 
schizophrenia who had a previous psychiatric history had a shorter LOS of around 2.5 421 
days, but this was not the case in the pooled model or for any of the other sub-groups. 422 
In the pooled model, patients from more deprived neighbourhoods had a longer LOS 423 
(between 2 and 3 days) and the effect was larger in patients with bipolar disorder (6 424 
days). Having a higher number of physical and psychiatric comorbidities was 425 
associated with longer LOS (1 day) while shorter LOS was associated with co-morbid 426 
substance or alcohol misuse (between 4 and 5 days), and co-morbid personality 427 
disorder (between 7 and 9 days) for all types of patient. Patients who decided to self-428 
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discharge had shorter LOS (between 19 and 29 days). Patients whose usual place of 429 
residence was an urban area did not have significantly different LOS compared with 430 
other patients. No association was found between LOS and primary care in terms of 431 
either access or quality variables.  432 
Hospital variation 433 
Figure 4 shows histograms of the estimated hospital fixed effects by diagnostic group. 434 
These fixed effects could be interpreted as the predicted length of stay for a given 435 
patient (here given by the reference category in Table 3). The median hospital effects 436 
were 42.8 days (Interquartile range (IQR) = 38.5 - 45.7) for schizophrenia (F20), 42.6 437 
days (IQR = 38.0 - 46.0) for schizotypal disorders (F21-F29), and 42.3 days (IQR = 438 
38.9 - 46.5) for bipolar and mood affective disorders (F30-F31). The differences 439 
amongst hospital fixed effects reflect the average effect on hospital LOS of 440 
differences across hospitals in factors that we do not observe.   441 
 442 
Figure 4 about here 443 
 444 
The correlations between the hospital effects for the three sub-groups of patients were 445 
high (rho>0.75) for all pairs of diagnostic groups.  446 
'LVFXVVLRQ 447 
To our knowledge, this is the first study to use large-scale national routine data to 448 
examine the key determinants of LOS for particular patient sub-groups with serious 449 
mental illness in England. Previous literature has tended to produce inconsistent 450 
results about factors associated with LOS partly because of small sample sizes and 451 
also due to the limitations of the methods employed in some studies. Our main 452 
contribution to the existing literature is in terms of our methodology which, compared 453 
to other studies, provides results which are more robust. The methodological advances 454 
include estimating a Poisson regression model with hospital fixed effects, rather than 455 
using a logit model to examine long-stay patients using an arbitrary cut-off point to 456 
model case-controls, and taking account of LOS as a continuous variable. Where 457 
many previous studies ignore hospital effects, we examined differences in LOS 458 
between mental health providers. Our larger sample size enabled us to improve on 459 
previous studies by estimating separate models for three key diagnostic sub-groups to 460 
analyse the independent contribution of a range of potential determinants of LOS on 461 
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each of the broad classes of diagnoses. Our study population was everyone admitted 462 
to an NHS mental health hospital in England with SMI over the period 2006 to 2010 463 
and was considerably larger and more representative than previous studies. There are 464 
no reliable estimates of the number of patients seeking care in the private sector, but 465 
this is likely to be small as the vast majority of mental health hospital care in England 466 
is publicly funded. Specifically, the £143 m market for privately funded mental health 467 
hospital care [49] compares with £2 billion of NHS spending on psychotic disorders 468 
[50]. 469 
 470 
Contrary to some previous studies, we found that diagnosis was a strong predictor of 471 
LOS [40, 51]. We found that shorter LOS was associated with co-morbid substance or 472 
alcohol misuse, and with co-morbid personality disorder, although recorded 473 
prevalence of these co-morbidities may be low due to poor coding. This finding is 474 
however consistent with previous literature and may be because when WKHVHSDWLHQWV¶475 
symptoms resolve following inpatient detoxification, they are more likely to leave 476 
against medical advice (self-discharge), and may be motivated to show improvement 477 
so they can leave to regain access to drugs or alcohol [35, 37]. Indeed patients who 478 
self-discharged had shorter LOS. It may also reflect the transient nature of psychotic 479 
symptoms in the context of substance misuse, where there is more rapid resolution 480 
upon admission to hospital and removal from the usual environment. While previous 481 
literature has been inconsistent with respect to the association with age, reporting 482 
positive [30, 33, 35], and negative findings [29, 31, 36]), in our study we found a 483 
strong age gradient only for people aged 55 and above (and the effect was not 484 
apparent until 65 for those with schizophrenia). We also found, as in previous 485 
literature [37, 38], that compulsory admission was positively associated with LOS, 486 
increasing it by 16 days overall (19 days for schizophrenia, 15 days for 487 
schizoaffective disorder and 17 days for bipolar disorder). While studies have found 488 
mixed results on the association between male gender and LOS (positive [24, 30, 31], 489 
negative [37]), gender was not a significant predictor of LOS in our analyses. 490 
Previous evidence on the association between co-morbidities and LOS has been 491 
inconsistent: while some studies found that patients with more co-morbidities had 492 
longer LOS [24, 29], others found that individuals with no comorbidity had longer 493 
LOS [30]. Our study found that having a higher number of psychiatric and physical 494 
comorbidities was associated with longer LOS of around 1 day. Some previous 495 
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studies have reported positive associations between prior hospitalisation and LOS [35, 496 
38] and others found a negative relationship [29]; in our analyses, only schizophrenia 497 
patients with a psychiatric history had a shorter LOS of around 2.5 days. This may be 498 
because these patients are well known to services and crisis stabilisation can be 499 
achieved more swiftly since relapse signatures will be familiar, medication regimes 500 
will be tried and tested, and care plans are more likely to be in place. 501 
 502 
Having a carer was associated with longer LOS overall in the pooled model and for 503 
schizophrenia and bipolar disorder patients, but there was no effect for schizoaffective 504 
disorder patients. It is possible that if carers experience a significant carer burden 505 
from patients with high levels of need, LOS may be prolonged, in the interests of 506 
SURWHFWLQJFDUHUV¶KHDOWKDQGZHOOEHLQJJust less than 7% of patients have an unpaid 507 
carer registered in their hospital record. The record may underestimate the actual level 508 
of both formal and informal care that this patient population receive. If a record of 509 
having a carer is associated with increased patient need, then this may explain the 510 
positive association that we observe.  511 
 512 
Patients with manic or bipolar disorders who were from more deprived 513 
neighbourhoods had longer LOS whilst this was not the case for schizophrenia 514 
patients.  515 
 516 
Although there were similarities in the association between LOS and patient 517 
characteristics across the three diagnostic patient groups, there were some noticeable 518 
differences. Whilst these should be interpreted with caution, our results suggest that 519 
there may be advantages to modelling LOS stratified by diagnostic groupings to more 520 
accurately determine associations between case-mix which can be used to ensure 521 
prospective payment systems reflect accurately the resource use within sub-groups.  522 
 523 
We found a large degree of variation in case-mix between providers. This will likely 524 
have implications for the costs imposed on them by the risk profile of their patient 525 
population, particularly if hospitals predominantly treat older patients with complex 526 
care needs and detained patients. We also found significant variation in the hospital 527 
fixed effects within diagnostic groupings. The interquartile range of the hospital fixed 528 
effects for each diagnostic group is around 9 days suggesting a significant spread in 529 
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the distribution and large differences between providers in the unexplained variation 530 
in LOS. We also found a high correlation between the provider effects across the 531 
different diagnostic groups. This suggests that hospitals with unexplained high LOS 532 
for one diagnostic group will also have high LOS for another sub-group. These 533 
hospitals may be systematically different in the way they manage and treat patients. 534 
Unobserved hospital characteristics (such as the quality of care, quality of 535 
management, unmeasured differences in average case-mix, or differences in 536 
efficiency) therefore appear to have similar effects on LOS for different types of 537 
patients.  538 
 539 
The proposed NTPS for mental health providers is based on need and, other than 540 
assigning patients to the super-classes of non-psychotic, psychosis and organic mental 541 
illness, the system does not directly use diagnoses (ICD-10 codes) to cluster service 542 
users. The Mental Health Clustering Tool, used to allocate service users to the 21 543 
clusters, explicitly states that people with the same diagnosis can be assigned to 544 
different clusters, and that individuals can move between clusters as their needs 545 
change over time [52]. Our results suggest that the payment system may need to be 546 
tailored according to diagnostic group. A prospective payment system should be fair 547 
(e.g. paying the same for treating patients with similar needs), but also needs to take 548 
account of factors beyond the control of a hospital (e.g. the characteristics of patients 549 
such as diagnosis if this affects LOS, age, detention status, local input prices). 550 
However, a balance needs to be struck. If some factors make little economic 551 
difference, though statistically significant, they should not be used in the payment 552 
system as they would add unnecessary complexity.  There are also risks of unintended 553 
consequences if some diagnoses or detention status attract a higher payment, 554 
generating inappropriate incentives. Finally, the argument for paying by diagnosis 555 
hinges on the assumption that these are well coded. There are therefore concerns 556 
about the feasibility of implementing such a system (coding quality, gaming, etc.). 557 
&RQFOXVLRQV 558 
This study used national administrative data linked to publicly available datasets to 559 
produce a large sample with a rich set of potential determinants of LOS for patients 560 
with SMI. Our data on individual patients was more limited than in studies adopting 561 
retrospective case note review but were comprehensive in that they covered all 562 
 - 19 - 
publicly funded hospital admissions in England. Many of the commonly identified 563 
risk factors were captured, although some were an imperfect match for those 564 
identified in the literature review. Other factors were omitted entirely due to limited 565 
data availability, including psychiatric functioning or severity, the use of seclusion or 566 
restraint and psychopharmacological medication. We also did not account for 567 
readmissions which may be important in relation to LOS and payment mechanisms, 568 
since providers with shorter LOS may benefit from early discharge, and a subsequent 569 
new admission for which they could be paid, unless incentives were put in place to 570 
discourage a quicker and sicker µUHYROYLQJGRRU¶SKHQRPHQRQ[53].   571 
 572 
We found substantial variation between providers in unobserved hospital 573 
characteristics (such as differences in management culture or efficiency). Providers 574 
appear to be systematically different in terms of their resource use and this will likely 575 
result in VRPHKRVSLWDOVEHLQJµZLQQHUV¶DQGRWKHUVµORVHUV¶XQGHUDSURVSHFWLYH576 
payment system. International experience suggests large variations in provider effects 577 
with respect to costs or LOS may make a classification system unsuitable for provider 578 
payment [13] as it may destabilize local health economies. There is therefore a need 579 
for a careful transition to any new payment system. 580 
 581 
The variation in case-mix which we observed may be the result of genuine differences 582 
in risk profiles between providers, but may also be due to inconsistent use of 583 
diagnostic codes between providers. There are some limitations to the use of 584 
diagnostic classifications in HES for psychiatric admissions. Diagnostic coding is 585 
often done by administrative staff removed from the nuances of psychiatric diagnosis, 586 
rather than by the rigorous application of ICD-10 criteria by clinicians. Whilst we 587 
have argued that payment systems may need to be tailored to diagnostic groupings, 588 
this would require the consistent and accurate use of diagnostic codes across mental 589 
health providers. Whilst some mental health professionals are reluctant to label 590 
patients, in part due to stigma, and argue for treating the person rather than the illness 591 
[54], diagnostic coding can be helpful to patients, by providing appropriate treatments 592 
and access to support and services including benefits [55]. A quality indicator has 593 
been recommended for use by commissioners and providers in drawing up contracts 594 
as part of the NTPS which incentivises the collection of a valid ICD-10 code [56]. 595 
Improved data quality on diagnostic coding is imperative for future research purposes 596 
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to better understand the role of diagnosis as a driver of LOS and resource use as part 597 
of a funding system.  598 
 599 
Challenges in future may be not just to reward hospitals properly but also to 600 
incorporate incentives for appropriate primary, community and social care to form 601 
part of the care package for individuals with SMI, moving towards personalised 602 
funding. Future research should therefore focus on examining cost drivers across the 603 
full range of services that SMI patients utilise and across the full patient care pathway. 604 
This will support the design and reimbursement of more effective and efficient care 605 
pathways. Inpatient LOS for SMI patients will remain an expensive but important 606 
component of that pathway and therefore understanding the key determinants of LOS 607 
is vital as mental health service commissioners and providers grapple with the 608 
challenges of continued cost pressures.  609 
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Table 1 - Descriptive statistics for admissions contributing to the regression analyses 
Variable Pooled 
(N=89,510) 
(1) 
Schizophrenia 
(N=38,216) 
(2) 
Psychotic and 
schizoaffective 
disorder 
(N=21,415) 
(3) 
Manic and 
bipolar disorder 
(N=29,879) 
(4) 
Main diagnosis (n, %)   
      Schizophrenia (F20) 38,216 (42.7) 38,216 (100.0) 
    Schizotypal disorder (F21) 229 (0.3) 
  
229 (1.1) 
  Persistent delusional disorder (F22) 3,605 (4.0) 
  
3,605 (16.8) 
  Acute and transient psychotic disorder (F23) 6,446 (7.2) 
  
6,446 (30.1) 
  Induced delusional disorder (F24) 66 (0.1) 
  
66 (0.3) 
  Schizoaffective disorders (F25) 8,200 (9.2) 
  
8,200 (38.3) 
  Other nonorganic psychotic disorders (F28) 268 (0.3) 
  
268 (1.3) 
  Unspecified nonorganic psychosis (F29) 2,601 (2.9) 
  
2,601 (12.1) 
  Manic episode (F30) 2,777 (3.1) 
    
2,777 (9.3) 
Bipolar affective disorder (F31) 27,102 (30.3) 
    
27,102 (90.7) 
Age (n, %)   
      Age up to 25 8,224 (9.2) 3,893 (10.2) 2,795 (13.1) 1,536 (5.1) 
Age 25-34 17,951 (20.1) 9,213 (24.1) 4,623 (21.6) 4,115 (13.8) 
Age 35-44 22,116 (24.7) 10,308 (27.0) 5,094 (23.8) 6,714 (22.5) 
Age 45-54 17,997 (20.1) 7,298 (19.1) 3,824 (17.9) 6,875 (23.0) 
Age 55-64 11,652 (13.0) 4,194 (11.0) 2,281 (10.7) 5,177 (17.3) 
Age 65-74 7,110 (7.9) 2,203 (5.8) 1,402 (6.5) 3,505 (11.7) 
Age 75 and over 4,460 (5.0) 1,107 (2.9) 1,396 (6.5) 1,957 (6.5) 
Gender (n, %)   
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Female 42,589 (47.6) 13,217 (34.6) 11,292 (52.7) 18,080 (60.5) 
Male 46,921 (52.4) 24,999 (65.4) 10,123 (47.3) 11,799 (39.5) 
Detention status (n, %)   
      Not detained 72,273 (80.7) 30,554 (80.0) 17,039 (79.6) 24,680 (82.6) 
Detained 17,237 (19.3) 7,662 (20.0) 4,376 (20.4) 5,199 (17.4) 
Ethnicity (n, %)   
      White 67,980 (75.9) 27,330 (71.5) 15,841 (74.0) 24,809 (83.0) 
Mixed 1,822 (2.0) 948 (2.5) 443 (2.1) 431 (1.4) 
Asian 6,728 (7.5) 3,290 (8.6) 1,684 (7.9) 1,754 (5.9) 
Black 8,898 (9.9) 5,051 (13.2) 2,172 (10.1) 1,675 (5.6) 
Unknown or missing 4,082 (4.6) 1,597 (4.2) 1,275 (6.0) 1,210 (4.0) 
Patient has a carer  (n, %)   
      No 83,426 (93.2) 35,647 (93.3) 19,958 (93.2) 27,821 (93.1) 
Yes 6,084 (6.8) 2,569 (6.7) 1,457 (6.8) 2,058 (6.9) 
Patient was previously treated for mental health issues (n, %)   
      No 48,126 (53.8) 19,377 (50.7) 12,803 (59.8) 15,946 (53.4) 
Yes 41,384 (46.2) 18,839 (49.3) 8,612 (40.2) 13,933 (46.6) 
Alcohol and substance misuse (n, %)   
      No 84,786 (94.7) 35,797 (93.7) 20,304 (94.8) 28,685 (96.0) 
Yes 4,724 (5.3) 2,419 (6.3) 1,111 (5.2) 1,194 (4.0) 
Co-morbid personality disorder (n, %)   
      No 88,329 (98.7) 37,800 (98.9) 21,077 (98.4) 29,452 (98.6) 
Yes 1,181 (1.3) 416 (1.1) 338 (1.6) 427 (1.4) 
Number of comorbidities (mean, sd) 0.43 (1.0) 0.39 (1.0) 0.47 (1.1) 0.45 (1.1) 
Discharge type (n, %)   
      Discharged by consultant 87,063 (97.3) 37,148 (97.2) 20,790 (97.1) 29,125 (97.5) 
Self-discharged 2,017 (2.3) 902 (2.4) 525 (2.5) 590 (2.0) 
Died in hospital 430 (0.5) 166 (0.4) 100 (0.5) 164 (0.5) 
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Resident in urban area (n, %)   
      No 8,959 (10.0) 2,782 (7.3) 2,251 (10.5) 3,926 (13.1) 
Yes 80,551 (90.0) 35,434 (92.7) 19,164 (89.5) 25,953 (86.9) 
Percentage mental health benefit claimants in local 
community (mean, sd) 2 (1.6) 2.51 (1.7) 2.23 (1.6) 2.03 (1.5) 
Percentage population of local community resident in NHS 
psychiatric establishment (mean, sd) 0 (0.3) 0.03 (0.4) 0.02 (0.3) 0.02 (0.3) 
GP quality - % practice population with SMI with care plan 
(mean, sd) 1 (0.1) 0.84 (0.1) 0.85 (0.1) 0.84 (0.1) 
GP access - % practice population able to see GP within 48h 
(mean, sd) 1 (0.1) 0.82 (0.1) 0.82 (0.1) 0.83 (0.1) 
 
 
Table 2 ± LOS by diagnostic group and pooled over time 
  
All (F20-F31) 
(1) 
Schizophrenia (F20) 
(2) 
Psychotic and 
schizoaffective 
disorder (F21-F29) 
(3) 
Manic and bipolar 
disorder 
(F30-F31) 
(4) 
Financial year Mean SD Mean SD Mean SD Mean SD 
2006/07 44.4 40.0 48.0 43.3 41.6 38.5 41.6 35.7 
2007/08 43.3 39.7 47.0 42.7 40.8 38.5 40.2 35.9 
2008/09 45.0 40.1 49.0 42.9 42.1 39.1 42.2 36.7 
2009/10 43.7 39.6 47.7 42.7 40.6 37.8 41.1 36.3 
2010/11 42.7 38.4 46.1 40.9 40.2 37.5 40.5 35.7 
Pooled 43.9 39.7 47.7 42.7 41.1 38.3 41.2 36.1 
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Table 3 - Factors determining hospital length of stay ± regression results, Average Partial Effects (APEs) 
 Pooled 
(F20-F31) 
(1) 
Schizophrenia (F20) 
(2) 
Psychotic and 
schizoaffective 
disorder (F21-F29) 
(3) 
 Manic and bipolar 
disorder 
(F30-F31) 
(4) 
Variable APE SE APE SE APE SE APE SE 
Main diagnosis 
        Schizophrenia (F20) (base category) (base category) 
   Schizotypal disorder (F21) -4.16 0.71 *** 
 
(base category)   
Persistent delusional disorder (F22) -19.56 1.04 ***   -2.12 2.86    
Acute and transient psychotic disorder (F23) -11.57 4.69 *   -17.20 2.15 ***   
Induced delusional disorder (F24) 0.75 0.52    -9.34 5.65    
Schizoaffective disorders (F25) -11.67 2.32 ***   3.78 3.18    
Other nonorganic psychotic disorders (F28) -11.42 1.10 ***   -9.29 3.79 *   
Unspecified nonorganic psychosis (F29) -6.36 0.48 ***   -9.03 2.69 ***   
Manic episode (F30) -3.02 2.80  
   
  (base category) 
Bipolar affective disorder (F31) -12.57 1.01 *** 
  
   7.42 1.27 *** 
Patient demographics and clinical characteristics 
    
   
  
 
Age 25-34 -1.63 0.61 ** -1.72 0.81 * -0.93 1.13  -2.64 1.44  
Age 35-44 -3.54 0.53 *** -3.84 0.76 *** -3.68 1.10 *** -3.65 1.37 ** 
Age 45-54 -2.25 0.59 *** -3.22 0.98 *** -2.25 1.00 * -0.66 1.42  
Age 55-64 1.64 0.63 ** -0.49 0.98  4.56 1.35 *** 4.31 1.80 * 
Age 65-74 10.88 1.23 *** 6.21 1.60 *** 14.39 2.33 *** 18.55 3.01 *** 
Age 75 and over 18.64 1.57 *** 11.60 2.45 *** 25.57 3.84 *** 27.45 3.73 *** 
Male -0.41 0.38  -1.35 0.53 * -0.62 0.62  0.72 0.77  
Detained 15.98 1.17 *** 19.48 1.81 *** 14.72 2.26 *** 16.51 1.76 *** 
Ethnicity: mixed 2.31 0.99 * 0.57 1.49  3.65 1.80 * 7.74 3.45 * 
Ethnicity: Asian 0.69 0.64  0.68 0.82  1.92 1.42  -0.45 0.89  
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Ethnicity: black 4.46 0.63 *** 5.28 0.93 *** 3.99 1.25 ** 4.88 1.70 ** 
Ethnicity: unknown or missing -0.77 0.72  0.10 1.21  -0.81 1.17  -2.31 1.87  
Patient has a carer 3.16 1.14 ** 3.19 1.35 * 1.44 1.64  5.50 2.22 * 
Patient was previously treated for mental health 
issues -1.00 0.76  -2.51 0.94 ** 0.15 0.94  0.41 1.22  
MH benefit claimants - 2nd quintile 0.63 0.41  -0.07 0.62  1.12 0.94  1.32 0.75  
MH benefit claimants - 3rd quintile 1.41 0.47 ** 0.59 0.67  1.24 1.00  3.14 0.97 ** 
MH benefit claimants - 4th quintile 2.43 0.78 ** 1.41 0.99  1.75 1.28  5.76 1.09 *** 
MH benefit claimants - 5th quintile 2.65 0.68 *** 1.11 0.88  3.03 1.34 * 6.08 1.13 *** 
Number of comorbidities 1.17 0.33 *** 1.04 0.35 ** 1.29 0.36 *** 1.53 0.53 ** 
Alcohol and substance misuse -4.21 0.67 *** -4.96 1.05 *** -2.40 1.38  -5.10 1.50 *** 
Co-morbid personality disorder -7.81 1.30 *** -9.14 2.19 *** -7.18 2.91 * -9.46 2.19 *** 
Discharge             
Self-discharged -19.99 1.85 *** -19.24 2.48 *** -20.37 3.11 *** -29.17 2.76 *** 
Died in hospital -3.30 1.64 * -3.56 2.73  -0.96 4.12  -6.03 3.09  
Access to care             
Urban 0.41 0.61  -0.10 0.91  0.67 1.02  1.20 1.06  
% residents of local community in psychiatric 
establishment -0.04 0.41  0.11 0.52  0.01 1.30  -0.41 0.87  
Ability to access GP within 48h -0.54 1.12  0.10 1.73  -2.74 2.68  0.10 2.79  
Care plan developed in primary care -1.01 0.95  -2.18 1.57  2.92 2.16  -1.70 2.23  
Time effects             
Year 2007 -1.18 0.97  -1.25 1.17  -1.27 1.45  -1.77 1.34  
Year 2008 0.22 0.86  0.49 1.06  -0.44 1.19  0.43 1.37  
Year 2009 -1.47 0.99  -1.34 1.33  -2.30 1.20  -1.79 1.33  
Year 2010 -3.08 1.15 ** -3.50 1.45 * -3.67 1.44 * -3.22 1.78  
Pseudo-R
2
 0.061 0.046 0.091 0.050 
N 89,510 38,216 21,415 29,879 
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Note: Evaluated at the mean of the estimated hospital effects. Interaction effects are subsumed into main effects. Pseudo-R2 are based on model with standard errors 
clustered at hospital level but no hospital fixed effects. 
* p<0.05; ** p<0.01; *** p<0.001 
 
Table 4 - Factors determining hospital length of stay ± regression results, Incidence Rate Ratios (IRRs) 
 Pooled 
(F20-F31) 
(1) 
Schizophrenia (F20) 
(2) 
Psychotic and 
schizoaffective 
disorder (F21-F29) 
(3) 
Manic and bipolar 
disorder 
(F30-F31) 
(4) 
Variable IRR 95% CI IRR 95% CI IRR 95% CI IRR 95% CI 
Main diagnosis   
      Schizophrenia (F20) (base category) (base category) 
    Schizotypal disorder (F21) 0.91 (0.88 ; 0.94) 
  
(base category) 
  Persistent delusional disorder (F22) 0.64 (0.62 ; 0.66) 
  
0.96 (0.84 ; 1.08) 
  Acute and transient psychotic disorder (F23) 0.77 (0.62 ; 0.95) 
  
0.69 (0.61 ; 0.78) 
  Induced delusional disorder (F24) 1.02 (0.99 ; 1.04) 
  
0.82 (0.63 ; 1.05) 
  Schizoaffective disorders (F25) 0.77 (0.69 ; 0.85) 
  
1.09 (0.96 ; 1.23) 
  Other nonorganic psychotic disorders (F28) 0.77 (0.74 ; 0.81) 
  
0.82 (0.68 ; 0.98) 
  Unspecified nonorganic psychosis (F29) 0.87 (0.85 ; 0.88) 
  
0.82 (0.72 ; 0.94) 
  Manic episode (F30) 0.93 (0.82 ; 1.06) 
    
(base category) 
Bipolar affective disorder (F31) 0.75 (0.72 ; 0.78) 
    
1.14 (1.10 ; 1.18) 
Patient demographics and clinical characteristics   
      Age 25-34 0.99 (0.93 ; 1.04) 1.00 (0.91 ; 1.10) 1.01 (0.93 ; 1.10) 0.96 (0.89 ; 1.03) 
Age 35-44 0.94 (0.90 ; 0.99) 0.95 (0.88 ; 1.03) 0.94 (0.86 ; 1.02) 0.95 (0.88 ; 1.02) 
Age 45-54 0.99 (0.94 ; 1.03) 0.98 (0.91 ; 1.07) 0.98 (0.91 ; 1.05) 1.00 (0.93 ; 1.08) 
Age 55-64 1.10 (1.05 ; 1.16) 1.06 (0.97 ; 1.15) 1.17 (1.07 ; 1.27) 1.12 (1.04 ; 1.21) 
Age 65-74 1.32 (1.25 ; 1.39) 1.23 (1.12 ; 1.34) 1.40 (1.30 ; 1.52) 1.37 (1.26 ; 1.48) 
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Age 75 and over 1.50 (1.41 ; 1.60) 1.34 (1.22 ; 1.48) 1.63 (1.47 ; 1.81) 1.56 (1.41 ; 1.72) 
Male 1.06 (1.00 ; 1.12) 1.04 (0.95 ; 1.13) 1.05 (0.96 ; 1.16) 1.06 (0.99 ; 1.14) 
Detained 1.41 (1.35 ; 1.47) 1.52 (1.45 ; 1.60) 1.35 (1.28 ; 1.42) 1.31 (1.25 ; 1.37) 
Ethnicity: mixed 1.07 (1.01 ; 1.13) 1.05 (0.97 ; 1.14) 1.09 (0.99 ; 1.19) 1.10 (0.99 ; 1.23) 
Ethnicity: Asian 1.03 (0.99 ; 1.06) 1.04 (0.99 ; 1.09) 1.04 (0.97 ; 1.12) 1.01 (0.97 ; 1.05) 
Ethnicity: black 1.12 (1.09 ; 1.15) 1.15 (1.10 ; 1.20) 1.11 (1.05 ; 1.17) 1.11 (1.04 ; 1.17) 
Ethnicity: unknown or missing 0.99 (0.95 ; 1.03) 1.03 (0.96 ; 1.09) 0.97 (0.91 ; 1.04) 0.95 (0.88 ; 1.02) 
Interaction: Detained + Ethnicity: mixed 0.94 (0.84 ; 1.06) 0.85 (0.74 ; 0.98) 0.98 (0.80 ; 1.20) 1.14 (0.92 ; 1.41) 
Interaction: Detained + Ethnicity: Asian 0.95 (0.89 ; 1.02) 0.91 (0.83 ; 1.00) 1.00 (0.91 ; 1.11) 0.93 (0.83 ; 1.05) 
Interaction: Detained + Ethnicity: black 0.93 (0.88 ; 0.98) 0.90 (0.85 ; 0.96) 0.91 (0.84 ; 0.99) 0.91 (0.84 ; 0.98) 
Interaction: Detained + Ethnicity: unknown or 
missing 0.99 (0.92 ; 1.06) 0.91 (0.82 ; 1.01) 1.03 (0.92 ; 1.16) 1.05 (0.90 ; 1.22) 
Patient has a carer 1.07 (1.02 ; 1.12) 1.07 (1.01 ; 1.13) 1.03 (0.96 ; 1.10) 1.10 (1.03 ; 1.17) 
Patient was previously treated for mental health 
issues 0.98 (0.94 ; 1.01) 0.95 (0.91 ; 0.99) 1.00 (0.96 ; 1.04) 1.01 (0.97 ; 1.05) 
MH benefit claimants - 2nd quintile 1.01 (1.00 ; 1.03) 1.00 (0.97 ; 1.03) 1.03 (0.99 ; 1.07) 1.02 (1.00 ; 1.05) 
MH benefit claimants - 3rd quintile 1.03 (1.01 ; 1.06) 1.01 (0.98 ; 1.04) 1.03 (0.99 ; 1.07) 1.06 (1.02 ; 1.09) 
MH benefit claimants - 4th quintile 1.06 (1.02 ; 1.09) 1.03 (0.99 ; 1.08) 1.04 (0.99 ; 1.09) 1.11 (1.07 ; 1.14) 
MH benefit claimants - 5th quintile 1.06 (1.03 ; 1.09) 1.03 (0.99 ; 1.07) 1.07 (1.01 ; 1.13) 1.11 (1.07 ; 1.15) 
Number of comorbidities 1.03 (1.01 ; 1.04) 1.02 (1.01 ; 1.04) 1.03 (1.01 ; 1.04) 1.03 (1.01 ; 1.05) 
Alcohol and substance misuse 0.90 (0.88 ; 0.93) 0.89 (0.85 ; 0.93) 0.95 (0.89 ; 1.01) 0.91 (0.86 ; 0.96) 
Co-morbid personality disorder 0.82 (0.77 ; 0.88) 0.80 (0.71 ; 0.90) 0.84 (0.73 ; 0.97) 0.84 (0.77 ; 0.91) 
Discharge   
      Self-discharged 0.55 (0.49 ; 0.62) 0.57 (0.50 ; 0.66) 0.56 (0.48 ; 0.66) 0.50 (0.44 ; 0.57) 
Died in hospital 0.93 (0.86 ; 1.00) 0.92 (0.81 ; 1.05) 0.98 (0.82 ; 1.17) 0.90 (0.80 ; 1.01) 
Access to care   
      Urban 1.01 (0.98 ; 1.04) 1.00 (0.96 ; 1.04) 1.01 (0.97 ; 1.06) 1.02 (0.99 ; 1.06) 
% residents of local community in psychiatric 
establishment 1.00 (0.98 ; 1.02) 1.00 (0.98 ; 1.03) 1.00 (0.95 ; 1.06) 0.99 (0.96 ; 1.02) 
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Ability to access GP within 48h 0.99 (0.94 ; 1.04) 1.00 (0.93 ; 1.08) 0.94 (0.83 ; 1.06) 1.00 (0.91 ; 1.10) 
Care plan developed in primary care 0.98 (0.94 ; 1.02) 0.95 (0.89 ; 1.02) 1.07 (0.98 ; 1.16) 0.97 (0.90 ; 1.05) 
Time effects   
      Year 2007 0.97 (0.93 ; 1.02) 0.97 (0.92 ; 1.02) 0.97 (0.92 ; 1.03) 0.97 (0.93 ; 1.02) 
Year 2008 1.00 (0.97 ; 1.04) 1.01 (0.97 ; 1.06) 0.99 (0.94 ; 1.04) 1.01 (0.96 ; 1.05) 
Year 2009 0.97 (0.92 ; 1.01) 0.97 (0.92 ; 1.03) 0.95 (0.91 ; 1.00) 0.97 (0.93 ; 1.01) 
Year 2010 0.93 (0.88 ; 0.98) 0.92 (0.86 ; 0.99) 0.92 (0.87 ; 0.98) 0.95 (0.89 ; 1.01) 
Pseudo-R
2
 0.061 0.046 0.091 0.050 
N 89,510 38,216 21,415 29,879 
Note: Model includes hospital fixed effects (not shown). Age x gender interactions suppressed. Pseudo-R2 are based on model with standard errors clustered at hospital 
level but no hospital fixed effects. 
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